| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 2.53e-05 | 2 | 101 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 2.53e-05 | 2 | 101 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 2.53e-05 | 2 | 101 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 2.53e-05 | 2 | 101 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 1.51e-04 | 4 | 101 | 2 | GO:0071614 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 1.51e-04 | 4 | 101 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 2.51e-04 | 5 | 101 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 2.51e-04 | 5 | 101 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 2.51e-04 | 5 | 101 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 6.95e-04 | 8 | 101 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 6.95e-04 | 8 | 101 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | SNAP receptor activity | 1.01e-03 | 39 | 101 | 3 | GO:0005484 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.35e-03 | 11 | 101 | 2 | GO:0101020 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 KIFBP RIPOR2 SMC1A FYCO1 SRGAP2 DZIP1 CFAP298 AK7 DNAH1 NCOR1 SRGAP2C ZPR1 CEP250 RP1L1 PDE4DIP DIAPH1 CCDC68 CROCC DNAH5 ARHGAP21 | 1.96e-08 | 1058 | 98 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 KIFBP RIPOR2 SMC1A SRGAP2 DZIP1 AK7 DNAH1 NCOR1 SRGAP2C ZPR1 CEP250 RP1L1 PDE4DIP CCDC68 CROCC DNAH5 | 4.58e-08 | 720 | 98 | 17 | GO:0000226 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RIPOR2 SRGAP2 DZIP1 ARHGAP35 CFAP298 AK7 DNAH1 SRGAP2C CEP89 CEP250 RP1L1 ATXN10 CROCC DNAH5 | 3.34e-06 | 670 | 98 | 14 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | RIPOR2 SRGAP2 DZIP1 ARHGAP35 CFAP298 AK7 DNAH1 SRGAP2C CEP89 CEP250 RP1L1 ATXN10 CROCC DNAH5 | 4.31e-06 | 685 | 98 | 14 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium assembly | DZIP1 ARHGAP35 CFAP298 AK7 DNAH1 CEP89 CEP250 RP1L1 ATXN10 CROCC DNAH5 | 8.47e-06 | 444 | 98 | 11 | GO:0060271 |
| GeneOntologyBiologicalProcess | cilium organization | DZIP1 ARHGAP35 CFAP298 AK7 DNAH1 CEP89 CEP250 RP1L1 ATXN10 CROCC DNAH5 | 1.62e-05 | 476 | 98 | 11 | GO:0044782 |
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 2.23e-05 | 2 | 98 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ROCK2 RIPOR2 SWAP70 RASGRF2 RASA3 SRGAP2 ARHGAP35 RIN2 ARHGAP21 NOTCH2 GRAP | 4.96e-05 | 538 | 98 | 11 | GO:0007264 |
| GeneOntologyBiologicalProcess | organelle assembly | RIPOR2 SMC1A DZIP1 ARHGAP35 CFAP298 AK7 DNAH1 PIKFYVE LMOD3 NCOR1 CEP89 CEP250 RP1L1 ATXN10 CROCC DNAH5 | 8.74e-05 | 1138 | 98 | 16 | GO:0070925 |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 1.72e-04 | 23 | 98 | 3 | GO:0043651 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 1.89e-04 | 333 | 98 | 8 | GO:0051056 | |
| GeneOntologyBiologicalProcess | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 2.21e-04 | 5 | 98 | 2 | GO:0021815 | |
| GeneOntologyCellularComponent | cilium | ERC1 DZIP1 ARHGAP35 CFAP298 AK7 DNAH1 PIK3R4 CEP89 CEP250 RP1L1 CCDC68 ATXN10 CROCC DNAH5 ANKS3 NOTCH2 | 4.69e-06 | 898 | 99 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | phagocytic vesicle | 1.03e-04 | 157 | 99 | 6 | GO:0045335 | |
| GeneOntologyCellularComponent | centriole | 1.69e-04 | 172 | 99 | 6 | GO:0005814 | |
| GeneOntologyCellularComponent | meiotic cohesin complex | 4.59e-04 | 7 | 99 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 6.53e-04 | 83 | 99 | 4 | GO:0030670 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 9.75e-04 | 10 | 99 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | cohesin complex | 1.19e-03 | 11 | 99 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | microtubule organizing center | ROCK2 ERC1 DZIP1 ARHGAP35 CEP89 CEP250 PDE4DIP DIAPH1 CCDC68 ATXN10 CROCC TAF1D | 1.33e-03 | 919 | 99 | 12 | GO:0005815 |
| Domain | srGAP2 | 1.49e-07 | 3 | 100 | 3 | IPR030252 | |
| Domain | FCH | 2.13e-04 | 22 | 100 | 3 | PF00611 | |
| Domain | FCH | 2.13e-04 | 22 | 100 | 3 | SM00055 | |
| Domain | FCH_dom | 2.44e-04 | 23 | 100 | 3 | IPR001060 | |
| Domain | F_BAR | 3.14e-04 | 25 | 100 | 3 | IPR031160 | |
| Domain | F_BAR | 3.14e-04 | 25 | 100 | 3 | PS51741 | |
| Domain | PH | 7.39e-04 | 278 | 100 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 7.55e-04 | 279 | 100 | 7 | PS50003 | |
| Domain | PH_domain | 7.71e-04 | 280 | 100 | 7 | IPR001849 | |
| Domain | GAF | 7.78e-04 | 8 | 100 | 2 | IPR003018 | |
| Domain | GAF | 7.78e-04 | 8 | 100 | 2 | SM00065 | |
| Domain | HR1 | 7.78e-04 | 8 | 100 | 2 | PF02185 | |
| Domain | GAF_dom-like | 9.97e-04 | 9 | 100 | 2 | IPR029016 | |
| Domain | - | 9.97e-04 | 9 | 100 | 2 | 3.30.450.40 | |
| Domain | Rho_GTPase_activation_prot | 1.28e-03 | 88 | 100 | 4 | IPR008936 | |
| Domain | PH | 1.45e-03 | 229 | 100 | 6 | PF00169 | |
| Domain | HEAT | 2.16e-03 | 48 | 100 | 3 | PF02985 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.48e-03 | 14 | 100 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.48e-03 | 14 | 100 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.48e-03 | 14 | 100 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.48e-03 | 14 | 100 | 2 | PF08393 | |
| Domain | MT | 2.48e-03 | 14 | 100 | 2 | PF12777 | |
| Domain | AAA_8 | 2.48e-03 | 14 | 100 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.48e-03 | 14 | 100 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.48e-03 | 14 | 100 | 2 | PF07728 | |
| Domain | DHC_fam | 2.85e-03 | 15 | 100 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.85e-03 | 15 | 100 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.85e-03 | 15 | 100 | 2 | PF03028 | |
| Domain | HEAT | 3.71e-03 | 58 | 100 | 3 | IPR000357 | |
| Domain | RhoGAP | 4.48e-03 | 62 | 100 | 3 | SM00324 | |
| Domain | RhoGAP | 4.69e-03 | 63 | 100 | 3 | PF00620 | |
| Domain | RHOGAP | 4.90e-03 | 64 | 100 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 4.90e-03 | 64 | 100 | 3 | IPR000198 | |
| Domain | - | 4.90e-03 | 64 | 100 | 3 | 1.10.555.10 | |
| Domain | - | 5.05e-03 | 391 | 100 | 7 | 2.30.29.30 | |
| Domain | SNARE | 5.58e-03 | 21 | 100 | 2 | PF05739 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 1.99e-06 | 69 | 77 | 6 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.16e-06 | 70 | 77 | 6 | M41806 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ROCK2 VRK2 SWAP70 RASGRF2 SNAP23 SRGAP2 ARHGAP35 RHPN2 DIAPH1 PDE5A ARHGAP21 GOLGA3 | 4.20e-06 | 439 | 77 | 12 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ROCK2 VRK2 SWAP70 RASGRF2 SNAP23 SRGAP2 ARHGAP35 RHPN2 DIAPH1 PDE5A ARHGAP21 GOLGA3 | 5.41e-06 | 450 | 77 | 12 | M27078 |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 1.14e-05 | 93 | 77 | 6 | MM15609 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.21e-05 | 142 | 77 | 7 | MM15576 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 1.21e-05 | 94 | 77 | 6 | M41818 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.66e-05 | 149 | 77 | 7 | M41805 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ROCK2 VRK2 SWAP70 RASGRF2 SNAP23 SRGAP2 ARHGAP35 PIK3R4 RHPN2 DIAPH1 PDE5A ARHGAP21 GOLGA3 | 4.48e-05 | 649 | 77 | 13 | MM15690 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.66e-05 | 175 | 77 | 7 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 6.41e-05 | 184 | 77 | 7 | M41809 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 7.15e-05 | 41 | 77 | 4 | MM15630 | |
| Pathway | REACTOME_RHOF_GTPASE_CYCLE | 7.87e-05 | 42 | 77 | 4 | M41821 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ROCK2 VRK2 SWAP70 RASGRF2 SNAP23 SRGAP2 ARHGAP35 PIK3R4 RHPN2 DIAPH1 PDE5A ARHGAP21 GOLGA3 | 1.28e-04 | 720 | 77 | 13 | M41838 |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 1.97e-04 | 53 | 77 | 4 | M41811 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 2.79e-04 | 58 | 77 | 4 | MM15602 | |
| Pathway | REACTOME_RHOQ_GTPASE_CYCLE | 2.98e-04 | 59 | 77 | 4 | M41812 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 4.08e-04 | 64 | 77 | 4 | MM15601 | |
| Pathway | WP_CILIOPATHIES | 5.01e-04 | 184 | 77 | 6 | M39880 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 5.74e-04 | 70 | 77 | 4 | MM15597 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 6.31e-04 | 31 | 77 | 3 | M39476 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 7.09e-04 | 74 | 77 | 4 | M41807 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 8.07e-04 | 8 | 77 | 2 | M27135 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.03e-03 | 9 | 77 | 2 | M27143 | |
| Pathway | KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT | 1.15e-03 | 38 | 77 | 3 | M17857 | |
| Pathway | WP_G13_SIGNALING | 1.15e-03 | 38 | 77 | 3 | M39606 | |
| Pathway | WP_G13_SIGNALING_PATHWAY | 1.24e-03 | 39 | 77 | 3 | MM15898 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.29e-03 | 10 | 77 | 2 | MM14644 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 1.30e-03 | 87 | 77 | 4 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 1.36e-03 | 88 | 77 | 4 | M41810 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.57e-03 | 11 | 77 | 2 | M27130 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.57e-03 | 11 | 77 | 2 | M655 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.57e-03 | 155 | 77 | 5 | M41808 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.73e-03 | 94 | 77 | 4 | MM15598 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 1.88e-03 | 12 | 77 | 2 | M48064 | |
| Pubmed | STX8 KIFBP VRK2 USE1 MTHFD1L SNAP23 LAMC1 SMPD4 NIBAN2 HEATR1 DZIP1 HM13 DPP9 CEP89 ZNF644 SIK2 ATXN10 GOLGA3 NOTCH2 HERC5 | 1.28e-08 | 1487 | 103 | 20 | 33957083 | |
| Pubmed | 2.52e-08 | 3 | 103 | 3 | 22559944 | ||
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 1.01e-07 | 4 | 103 | 3 | 22559943 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | USP53 NES ERC1 LAMC1 SRGAP2 DZIP1 PIK3R4 CEP89 AASS SIK2 PPIP5K2 ARHGAP21 NOTCH2 TP53BP2 | 2.62e-07 | 861 | 103 | 14 | 36931259 |
| Pubmed | RASGRF2 SMC1A LAMC1 DZIP1 PPP1R7 NCOR1 PDE4DIP ATXN10 MGA ARHGAP21 NOTCH2 | 2.78e-07 | 497 | 103 | 11 | 23414517 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SECISBP2L MTA2 ROCK2 KIFBP FOXK2 ERC1 SMC1A SRGAP2 HEATR1 HM13 PPP1R7 PDE5A ATXN10 PPIP5K2 ANKS3 TP53BP2 CCDC144A | 3.38e-07 | 1321 | 103 | 17 | 27173435 |
| Pubmed | ROCK2 RASA3 SNAP23 SRGAP2 NIBAN2 DZIP1 CEP89 ARHGAP21 GOLGA3 NOTCH2 | 5.26e-07 | 421 | 103 | 10 | 36976175 | |
| Pubmed | MTA2 STX8 MYH4 ERC1 SMC1A SNAP23 FYCO1 PIK3R4 GOLGA3 TP53BP2 | 7.38e-07 | 437 | 103 | 10 | 20562859 | |
| Pubmed | ROCK2 NES KIFBP ERC1 FYCO1 SRGAP2 PPP1R7 NCOR1 PDE4DIP DIAPH1 MGA ARHGAP21 GOLGA3 TP53BP2 | 9.93e-07 | 963 | 103 | 14 | 28671696 | |
| Pubmed | 1.40e-06 | 8 | 103 | 3 | 16462940 | ||
| Pubmed | 7.56e-06 | 568 | 103 | 10 | 37774976 | ||
| Pubmed | 7.98e-06 | 339 | 103 | 8 | 37232246 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16198656 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15174222 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 8.69e-06 | 2 | 103 | 2 | 15569425 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19836472 | ||
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 8.69e-06 | 2 | 103 | 2 | 18511451 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24131248 | ||
| Pubmed | Developmental expression of human hepatic CYP2C9 and CYP2C19. | 8.69e-06 | 2 | 103 | 2 | 14634042 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11971956 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32567426 | ||
| Pubmed | CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. | 8.69e-06 | 2 | 103 | 2 | 10908295 | |
| Pubmed | Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. | 8.69e-06 | 2 | 103 | 2 | 17868191 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32868386 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27617498 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 1847130 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16873909 | ||
| Pubmed | Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. | 8.69e-06 | 2 | 103 | 2 | 17599801 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 31822692 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27373832 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 106274 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15385837 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 25518510 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15776277 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 16339073 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15842554 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 24492587 | ||
| Pubmed | Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis. | 8.69e-06 | 2 | 103 | 2 | 37343720 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19136640 | ||
| Pubmed | Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage. | 8.69e-06 | 2 | 103 | 2 | 35748067 | |
| Pubmed | Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days. | 8.69e-06 | 2 | 103 | 2 | 16232205 | |
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 8.69e-06 | 2 | 103 | 2 | 32587777 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20845310 | ||
| Pubmed | C-NAP1 and rootletin restrain DNA damage-induced centriole splitting and facilitate ciliogenesis. | 8.69e-06 | 2 | 103 | 2 | 23070519 | |
| Pubmed | Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. | 8.69e-06 | 2 | 103 | 2 | 17201743 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32683556 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 15855721 | ||
| Pubmed | Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. | 8.69e-06 | 2 | 103 | 2 | 9721182 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19847408 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17504998 | ||
| Pubmed | Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors. | 8.69e-06 | 2 | 103 | 2 | 24519941 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 14623888 | ||
| Pubmed | Cytochrome P450 polymorphisms in patients with Behcet's disease. | 8.69e-06 | 2 | 103 | 2 | 17269966 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 11950794 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17279092 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 22589111 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 32216088 | ||
| Pubmed | cDNA cloning and sequence of CYP2C29 encoding P-450 MUT-2, a microsomal aldehyde oxygenase. | 8.69e-06 | 2 | 103 | 2 | 8130255 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19534586 | ||
| Pubmed | CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. | 8.69e-06 | 2 | 103 | 2 | 15660966 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 18154472 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 27353638 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17298483 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 33115391 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17562299 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 36960518 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 26690534 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 33232775 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19199010 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 17304159 | ||
| Pubmed | Genetic Polymorphisms of CYP2C9/CYP2C19 in Chronic Obstructive Pulmonary Disease. | 8.69e-06 | 2 | 103 | 2 | 32757668 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19358898 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20390258 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 19761366 | ||
| Pubmed | Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations. | 8.69e-06 | 2 | 103 | 2 | 14616425 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 34438105 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 12496751 | ||
| Pubmed | Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype. | 8.69e-06 | 2 | 103 | 2 | 24403552 | |
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 2895926 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20831536 | ||
| Pubmed | 8.69e-06 | 2 | 103 | 2 | 20708153 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | USP53 ERC1 MTHFD1L SNAP23 PPP1R7 NCOR1 AASS CEP250 PPIP5K2 MGA ARHGAP21 TP53BP2 | 8.70e-06 | 853 | 103 | 12 | 28718761 |
| Pubmed | NES VRK2 SNAP23 SMPD4 SRGAP2 HM13 PIKFYVE DIAPH1 PPIP5K2 CROCC MGA | 1.16e-05 | 733 | 103 | 11 | 34672954 | |
| Pubmed | 1.18e-05 | 472 | 103 | 9 | 38943005 | ||
| Pubmed | 1.97e-05 | 504 | 103 | 9 | 34432599 | ||
| Pubmed | 2.26e-05 | 190 | 103 | 6 | 24816252 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 28687336 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 16220110 | ||
| Pubmed | Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technology. | 2.60e-05 | 3 | 103 | 2 | 15090156 | |
| Pubmed | Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus? | 2.60e-05 | 3 | 103 | 2 | 19192051 | |
| Pubmed | Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran. | 2.60e-05 | 3 | 103 | 2 | 20885015 | |
| Pubmed | Association of genetic polymorphisms with warfarin dose requirements in Chinese patients. | 2.60e-05 | 3 | 103 | 2 | 23941071 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 22708815 | ||
| Pubmed | Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphisms. | 2.60e-05 | 3 | 103 | 2 | 17827141 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23834474 | ||
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 2.60e-05 | 3 | 103 | 2 | 8530044 | |
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 23469989 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 21173785 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 38740087 | ||
| Pubmed | 2.60e-05 | 3 | 103 | 2 | 21108610 | ||
| Interaction | RAC3 interactions | ROCK2 STX8 VRK2 SWAP70 RASA3 SNAP23 SMPD4 SRGAP2 NIBAN2 ARHGAP35 CEP89 DIAPH1 ARHGAP21 NOTCH2 | 3.19e-06 | 619 | 103 | 14 | int:RAC3 |
| Interaction | EPHA2 interactions | ROCK2 RASA3 USE1 AXL SNAP23 SRGAP2 NIBAN2 DZIP1 CEP89 PHLPP1 MAP2K5 ARHGAP21 GOLGA3 NOTCH2 | 1.74e-05 | 719 | 103 | 14 | int:EPHA2 |
| Interaction | PAX6 interactions | FOXK2 CXorf38 SMC1A FYCO1 CFAP298 NCOR1 ZNF644 DIAPH1 MLLT6 MGA | 1.82e-05 | 366 | 103 | 10 | int:PAX6 |
| Interaction | CXADR interactions | VRK2 RASA3 SNAP23 SMPD4 NIBAN2 DZIP1 NCOR1 CEP89 GOLGA3 NOTCH2 | 1.95e-05 | 369 | 103 | 10 | int:CXADR |
| Interaction | RHOA interactions | ROCK2 STX8 VRK2 RIPOR2 RASGRF2 USE1 SNAP23 SMPD4 NIBAN2 HEATR1 ARHGAP35 HM13 RHPN2 CEP89 DIAPH1 ARHGAP21 GOLGA3 NOTCH2 | 3.39e-05 | 1199 | 103 | 18 | int:RHOA |
| Interaction | GJA1 interactions | ROCK2 VRK2 RASA3 SNAP23 SMPD4 NIBAN2 DZIP1 PIK3R4 CEP89 ARHGAP21 GOLGA3 NOTCH2 | 4.27e-05 | 583 | 103 | 12 | int:GJA1 |
| Interaction | ZYX interactions | SECISBP2L FOXK2 RASGRF2 NIBAN2 FBXO10 ZPR1 ARHGAP21 NOTCH2 TP53BP2 | 4.82e-05 | 329 | 103 | 9 | int:ZYX |
| Interaction | RAB9A interactions | STX8 VRK2 SMC1A SNAP23 SMPD4 FYCO1 NIBAN2 HM13 PIK3R4 PIKFYVE GOLGA3 NOTCH2 | 5.20e-05 | 595 | 103 | 12 | int:RAB9A |
| Interaction | RALBP1 interactions | 7.10e-05 | 198 | 103 | 7 | int:RALBP1 | |
| Interaction | RND3 interactions | 8.01e-05 | 273 | 103 | 8 | int:RND3 | |
| Interaction | YWHAZ interactions | RIPOR2 RASGRF2 ERC1 AXL SMC1A LAMC1 SRGAP2 DZIP1 NCOR1 CEP89 AASS ZNF644 SIK2 PPIP5K2 MAP2K5 ARHGAP21 GOLGA3 TP53BP2 | 1.16e-04 | 1319 | 103 | 18 | int:YWHAZ |
| Interaction | CDC42 interactions | ROCK2 STX8 KIFBP VRK2 RASGRF2 RASA3 USE1 SNAP23 SMPD4 NIBAN2 HEATR1 ARHGAP35 AASS DIAPH1 SIK2 ARHGAP21 NOTCH2 TRIM60 | 1.20e-04 | 1323 | 103 | 18 | int:CDC42 |
| Interaction | STX7 interactions | STX8 VRK2 SWAP70 USE1 SNAP23 SMPD4 NIBAN2 HM13 CEP89 ARHGAP21 GOLGA3 NOTCH2 | 1.37e-04 | 659 | 103 | 12 | int:STX7 |
| Interaction | IL17RA interactions | 1.45e-04 | 155 | 103 | 6 | int:IL17RA | |
| Interaction | CDH1 interactions | ROCK2 SWAP70 ERC1 SNAP23 SRGAP2 NIBAN2 UBE2T DIAPH1 PHLPP1 ARHGAP21 GOLGA3 NOTCH2 TP53BP2 | 1.46e-04 | 768 | 103 | 13 | int:CDH1 |
| Interaction | RHOD interactions | ROCK2 VRK2 RASA3 SNAP23 SMPD4 NIBAN2 ARHGAP35 CEP89 DIAPH1 ARHGAP21 NOTCH2 | 1.65e-04 | 572 | 103 | 11 | int:RHOD |
| Interaction | RHOF interactions | ROCK2 VRK2 RASA3 SNAP23 SRGAP2 NIBAN2 PIKFYVE CEP89 DIAPH1 ATXN10 ARHGAP21 NOTCH2 | 1.66e-04 | 673 | 103 | 12 | int:RHOF |
| Interaction | RAB35 interactions | VRK2 SNAP23 SMPD4 NIBAN2 DZIP1 HM13 CEP89 DIAPH1 ARHGAP21 GOLGA3 NOTCH2 | 1.67e-04 | 573 | 103 | 11 | int:RAB35 |
| Interaction | EMD interactions | NEPRO VRK2 CYP2C9 USE1 AXL SMPD4 FYCO1 HM13 NCOR1 SIK2 MAP2K5 GOLGA3 NOTCH2 | 1.91e-04 | 789 | 103 | 13 | int:EMD |
| Interaction | UBR1 interactions | 1.91e-04 | 163 | 103 | 6 | int:UBR1 | |
| Interaction | NDC80 interactions | 2.01e-04 | 312 | 103 | 8 | int:NDC80 | |
| Interaction | CYP2C9 interactions | 2.04e-04 | 105 | 103 | 5 | int:CYP2C9 | |
| Cytoband | 17p11.2 | 3.11e-05 | 159 | 103 | 5 | 17p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 9.91e-05 | 203 | 103 | 5 | chr17p11 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 8.17e-05 | 23 | 67 | 3 | 1288 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-04 | 206 | 67 | 6 | 682 | |
| GeneFamily | Ankyrin repeat domain containing | 2.73e-04 | 242 | 67 | 6 | 403 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 8.42e-04 | 50 | 67 | 3 | 721 | |
| GeneFamily | SNAREs|BCL2 homology region 3 (BH3) only | 1.38e-03 | 15 | 67 | 2 | 1124 | |
| GeneFamily | Dyneins, axonemal | 1.77e-03 | 17 | 67 | 2 | 536 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L ROCK2 FOXK2 SWAP70 ERC1 LAMC1 SRGAP2 ARHGAP35 PIK3R4 PIKFYVE RIN2 PHLPP1 PPIP5K2 TP53BP2 | 6.57e-06 | 856 | 103 | 14 | M4500 |
| Coexpression | ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP | 7.70e-06 | 119 | 103 | 6 | M41139 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.91e-06 | 171 | 103 | 6 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 5.83e-06 | 193 | 103 | 6 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 6.19e-06 | 195 | 103 | 6 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | f3c710f0fc8a7bfb5371d1aff6e3d8f266953153 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | 70a06fd7fb8de2c8ec3e3182e4476ced049daeae | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-CALB1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | 1639982d9d994918f7912d12d9d7cfcbc9da4145 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 142 | 103 | 5 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-05 | 145 | 103 | 5 | 9743d68ba8bfef56fd9a979ab357c0e287eb5ae2 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-05 | 152 | 103 | 5 | 18194f757d319958f26e5a91f56d89f25711236f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.75e-05 | 162 | 103 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.71e-05 | 177 | 103 | 5 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 178 | 103 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-05 | 178 | 103 | 5 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 6.68e-05 | 183 | 103 | 5 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 103 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-05 | 183 | 103 | 5 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.04e-05 | 185 | 103 | 5 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 187 | 103 | 5 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 188 | 103 | 5 | 1f07e3ab87173426fe0c429f5c084fb3425effd3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 188 | 103 | 5 | 85746f95319e494efdc1bbc24331698688d3a900 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 188 | 103 | 5 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 188 | 103 | 5 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 7.98e-05 | 190 | 103 | 5 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.98e-05 | 190 | 103 | 5 | ed100e271aac82806f59e0c613ccda63f59100c1 | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 8.38e-05 | 192 | 103 | 5 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 8.59e-05 | 193 | 103 | 5 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.59e-05 | 193 | 103 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.59e-05 | 193 | 103 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.80e-05 | 194 | 103 | 5 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 8.80e-05 | 194 | 103 | 5 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 8.80e-05 | 194 | 103 | 5 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 9.01e-05 | 195 | 103 | 5 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Glia_progenitor_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 9.23e-05 | 196 | 103 | 5 | 7be50b9156394dea44d7b8b476d4dd516abfafae | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.46e-05 | 197 | 103 | 5 | 937b70269cec8a4bdf4aaf8baa908c12bc309dc0 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1_high|Mild / Condition, Lineage, Cell class and cell subclass | 9.69e-05 | 198 | 103 | 5 | 17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-05 | 198 | 103 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 9.92e-05 | 199 | 103 | 5 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 9.92e-05 | 199 | 103 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.92e-05 | 199 | 103 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | COVID-mono1|COVID / Condition, Cell_class and T cell subcluster | 1.02e-04 | 200 | 103 | 5 | bd002c54305c746c07b7418a2084195e9c852ec5 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK---L2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 6ebdae4438bc64c6620416f64a7e22fbca2664bf | |
| ToppCell | COVID-mono1-|COVID / Condition, Cell_class and T cell subcluster | 1.02e-04 | 200 | 103 | 5 | 445a1aab962673dcc926c33ce9bed5ede9c41c57 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 081ca331b56f85167acfc73af9d2e91f398f8c4d | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 66e2f3e2e9063f17b47621120eb6009405f69e7e | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-LTK|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 940892bea41fde567f138a896d151acccef03a6a | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.57e-04 | 117 | 103 | 4 | 089793a950e8593b4acc1ba6a5e5474682f5fda6 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-04 | 117 | 103 | 4 | 3d98d77b4725d684e7496059e8b0ffffbe40301d | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 3.21e-06 | 197 | 103 | 8 | 5410_DN | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; PC3; HT_HG-U133A | 3.33e-06 | 198 | 103 | 8 | 3987_DN | |
| Drug | trapoxin | 6.51e-06 | 58 | 103 | 5 | CID000121875 | |
| Disease | X-11308 measurement | 6.11e-06 | 11 | 100 | 3 | EFO_0800693 | |
| Disease | X-21258 measurement | 3.40e-05 | 3 | 100 | 2 | EFO_0800802 | |
| Disease | Primary ciliary dyskinesia | 2.49e-04 | 36 | 100 | 3 | cv:C0008780 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0020829 | |
| Disease | X-17653 measurement | 4.03e-04 | 9 | 100 | 2 | EFO_0800783 | |
| Disease | Primary Ciliary Dyskinesia | 5.50e-04 | 47 | 100 | 3 | C4551720 | |
| Disease | cytochrome p450 3a4 measurement | 6.13e-04 | 11 | 100 | 2 | EFO_0020303 | |
| Disease | thymol sulfate measurement | 7.34e-04 | 12 | 100 | 2 | EFO_0021170 | |
| Disease | pre-eclampsia (implicated_via_orthology) | 8.66e-04 | 13 | 100 | 2 | DOID:10591 (implicated_via_orthology) | |
| Disease | X-17654 measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0800784 | |
| Disease | lysophosphatidylcholine measurement | 1.24e-03 | 62 | 100 | 3 | EFO_0010224 | |
| Disease | lymphocyte count | ROCK2 CYP2C19 RIPOR2 CYP2C9 RASA3 E2F2 NCOR1 ZNF800 ZNF644 PHLPP1 PPIP5K2 GOLGA3 NOTCH2 | 1.34e-03 | 1464 | 100 | 13 | EFO_0004587 |
| Disease | Hypertriglyceridemia | 1.87e-03 | 19 | 100 | 2 | EFO_0004211 | |
| Disease | hemoglobin A1 measurement | 1.98e-03 | 520 | 100 | 7 | EFO_0007629 | |
| Disease | COVID-19, osteoarthritis | 2.08e-03 | 20 | 100 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | progression free survival, ovarian serous carcinoma | 2.51e-03 | 22 | 100 | 2 | EFO_0004920, EFO_1001516 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TNMEQLLEKQGDGEA | 701 | P55198 | |
| QNQDLIAKMEEQGLA | 431 | Q9UBB4 | |
| KGDTLKILNMEDDQN | 21 | Q8TC17 | |
| QQELQKDKEAMALAN | 411 | Q9UK96 | |
| KGDTLKILNMEDDQN | 21 | Q13588 | |
| QEANMGLLDEILKQE | 116 | Q9UDR5 | |
| MLLQQQLDDARNKAD | 1166 | Q8N2N9 | |
| KMLNSELENGKENQE | 706 | Q8IYA2 | |
| IQEMEGLKNNLKEQD | 261 | Q9H2F9 | |
| QKREQLIDMNAEGDE | 1181 | O60610 | |
| GDDNLMQEINQNLAE | 106 | Q6UB35 | |
| SNGKLVEEIEQMNNL | 206 | Q13625 | |
| TIQKDGLDNDVEQQM | 811 | P58397 | |
| LQEREFEANKLQGMQ | 106 | Q5VWP3 | |
| AGEMIDNLLQDDQNI | 211 | Q9H4I0 | |
| ENELQKMTRGQLQDE | 1061 | Q8IUD2 | |
| LVEGESDNRNQQKME | 161 | O94776 | |
| KLKDGENLENNMENL | 416 | Q14644 | |
| DMNLNVINEGGIDKL | 371 | Q96TA1 | |
| MLLQQQLDDARNKAD | 1591 | Q5JPF3 | |
| LLKNGANRDMQDNKE | 1996 | Q04721 | |
| QDLLKNEQNQEEMTL | 101 | Q8IV33 | |
| MEEKQQIILANQDGG | 1 | Q8IWI9 | |
| NDPDMKELNLNNIEN | 251 | Q0VAK6 | |
| DLNLMADNSQPENEK | 231 | Q01167 | |
| AAQEMQELGEKLQAL | 396 | Q9BQS8 | |
| NNLAFNEIKILGMEE | 1791 | O43451 | |
| DNGNEDLAEILQIAM | 146 | Q06547 | |
| ELKKILANGQMNEQD | 151 | Q13163 | |
| LAEQQEKMLINGESG | 856 | O76074 | |
| ENQELMKSLEGNLET | 631 | P48681 | |
| QDLLEKGLEANNFAM | 246 | Q8TCT9 | |
| GMEELQAQLEKELQN | 256 | P18054 | |
| QLQGIEADMLDQEAA | 641 | Q08378 | |
| GILDINFLINKMQED | 26 | P15248 | |
| NLAEMIQKGEQLFLE | 516 | Q9NXE4 | |
| AEENGNVQALLEMLK | 561 | Q9UII4 | |
| NLELLREENGEKQAM | 591 | Q9Y2I7 | |
| IQIMDQNNFQEKLEG | 941 | Q9P2D7 | |
| AMDEIKSQELNLEGQ | 56 | A4FU69 | |
| NMQGLTDDQIEELKL | 61 | P57076 | |
| LAQQQMQSDLDKADL | 381 | Q5TZA2 | |
| DQQFLNLMEKLNENI | 191 | P33261 | |
| GQELKELMNTEQALD | 211 | Q14209 | |
| ELNGNQLMEKRETEG | 361 | P57773 | |
| GALKNQMGQVEIEDQ | 691 | Q86TI2 | |
| KQAQELVDENDGLKM | 306 | Q96ST8 | |
| RQDMQEAQGEQKELS | 1086 | Q9BV73 | |
| KILNLGNEGNQEMLQ | 856 | Q86WZ0 | |
| LAFLQELNEKMQQAD | 436 | P09913 | |
| LLQQGAELEMKDIQG | 121 | Q6ZW76 | |
| ANNIKMEAENLEQLI | 1286 | P11047 | |
| DLDNEVNNMLKQLQE | 1456 | P11047 | |
| NNEDLRNGLTEDMQK | 281 | Q8TB03 | |
| DGQNANNLELEEMER | 341 | Q9BSE4 | |
| NQKMIELLADNINLG | 661 | Q9H583 | |
| DQQFLNLMEKLNENI | 191 | P11712 | |
| NGKQNQERLEIEMES | 901 | A2RUR9 | |
| VIEGLENNNKLTMLD | 266 | Q15435 | |
| QLSMQDNIGELDLDK | 326 | Q96EK5 | |
| MQDLQKAQAELDDKQ | 3441 | Q8TE73 | |
| LRLEMPNEDQNENNE | 356 | Q96CM3 | |
| QNEANAEALKEMLGD | 81 | Q8NC24 | |
| QDFELNNELKMNVLN | 931 | O14827 | |
| SLKQMNVGEDLENED | 176 | Q9H5J8 | |
| GLSNKENRLEENEMI | 241 | Q15761 | |
| GLSEQENNEKQMRQL | 386 | O75376 | |
| KNMNLEGSIQDLFEL | 96 | Q6NW34 | |
| LKDMALNIGNEIDAQ | 166 | O00161 | |
| RDLKAENLLLDNNMN | 141 | Q9H0K1 | |
| ENLLLDNNMNIKIAD | 146 | Q9H0K1 | |
| DLGDMLAALEKQQQA | 491 | Q93073 | |
| GQQLQDDLMKVLNEL | 146 | P0DJJ0 | |
| GQQLQDDLMKVLNEL | 146 | P0DMP2 | |
| MSNLQGKIEDEQALA | 1091 | Q9Y623 | |
| TDQLGLEQDFEQKQM | 136 | Q9NRY4 | |
| NSDLQMLKEELEGLN | 81 | Q8IUC4 | |
| EQNLMEKLETLGINA | 546 | Q86YF9 | |
| QDLNQEVMNLDDILK | 626 | Q9Y4F9 | |
| MNFIKEENLDGNLNE | 291 | Q8TBZ0 | |
| DENAKNSELNLVGMI | 281 | Q70EK8 | |
| FLELVQLKNLNMEND | 496 | Q99570 | |
| QLKNLNMENDPNNEE | 501 | Q99570 | |
| QNLQEKLAEEMLGLA | 166 | Q9NZ43 | |
| KSEAQLEELAQMGLN | 196 | Q8WYP3 | |
| DQNEELGLNDMKTEG | 436 | O75312 | |
| NNIANINDDMLEGLE | 516 | O15455 | |
| GLQDNDLLDQMAAEL | 1546 | Q8IWN7 | |
| GQQLQDDLMKVLNEL | 146 | O75044 | |
| MEGQLNQDDSILKVA | 551 | P30530 | |
| QDKDQMDDLRAQILG | 26 | Q9NPD8 | |
| ERQDADGQMKELQDQ | 851 | O75116 | |
| DGQMKELQDQLEAEQ | 856 | O75116 | |
| DEINKELNQVMEQLG | 471 | Q14683 | |
| KQMGQEIGNELDEQN | 166 | Q9UNK0 | |
| QDEEMNILAKLNENL | 206 | Q495X7 | |
| LNVLNGLANNMDDLK | 16 | Q9H582 | |
| GLANNMDDLKINTDI | 21 | Q9H582 | |
| ELGLVQFKDLNMNVN | 31 | Q9HBG4 | |
| LQMDDNLPDVNDKQS | 96 | Q2TB10 | |
| NKLGDLDAMIFNNIE | 841 | O60346 | |
| LKEQALQEAMEQLEQ | 491 | Q9UH65 | |
| LMELGQNNDSEIEEN | 441 | O43314 | |
| QEELNKGMADIDIQD | 1196 | Q5T5U3 | |
| LQKMLDQAENELENG | 136 | Q15696 | |
| EEKLIGLMNNEAAQE | 381 | Q86Y07 | |
| LDGIKESMEQNAGQL | 441 | Q96M32 | |
| EAQQELQMLQKQLGE | 1741 | Q5VU43 |